Micronoma in the News

After controlling for high levels of bacterial contamination in their lab and reagents, researchers detect microbial genetic material in plasma samples from healthy people and cancer patients. Read the full article in The Scientist

Micronoma, a San Diego, Calif.-based cancer detection biotech company that utilizes signals from the tumor-related microbiome to diagnose cancer at an early stage with liquid biopsy technology, closed a $3.5m convertible debt financing round. Read full story.

Read the article at CIO Applications

San Diego-based Micronoma, a startup using microbiome analysis for early cancer detection, has appointed Magda Marquet as chairman of the firm’s board.

Microbiomics is taking a sharp turn. Until now, the field was limited to fecal transplants from healthy patients to those with gut conditions. The transplant is an awkward procedure that also creates regulatory and other challenges. Read More.

A San Diego-based biotech firm that has co-founders from UC San Diego is working to develop and commercialize a minimally invasive method for early cancer detection and recently closed a $3 million seed financing round to further its results. Read full story at La...

Micronoma, an early cancer-detection biotech that seeks to develop and commercialize a minimally invasive, microbiome-based method, announced today that it has closed a $3 million seed financing round led by microbiome-focused investor, SymBiosis, LLC. Read More.

San Diego-based Micronoma closed $3 million in seed financing to support the development of its microbiome-based cancer detection technology. Full Article

13 Aug. 2020. A new company, spun off from university biomedical engineering labs, is creating early cancer diagnostics by analyzing microbial genetics in simple blood samples. Micronoma, in San Diego, is also raising $3 million in its seed funding round, equity...

  A study suggests the potential for a noninvasive diagnostic that could detect tumors early and differentiate between disease types. Read More.

The story behind this paper begins with the loss of my grandmother to pancreatic cancer and the relentless pursuit to understand her disease. Projects along my educational path seemed like diversions (e.g. infectious disease genomics) but provided valuable skills to...

From a simple blood draw, microbial DNA may reveal who has cancer and which type, even at early stages When Gregory Poore was a freshman in college, his otherwise healthy grandmother was shocked to learn that she had late-stage pancreatic cancer. The condition was...